257OINTENSE DOSE-DENSE EPIRUBICIN (E), PACLITAXEL (T), CYCLOPHOSPHAMIDE (C) (IDDETC) IS HIGHLY EFFECTIVE IN ADJUVANT THERAPY OF NODE-POSITIVE BREAST CANCER PATIENTS (PTS). AN ANALYSIS OF THE GBG, AGO-B, AND NOGGO STUDY GROUPS.

@article{Thomssen2014257OINTENSEDE,
  title={257OINTENSE DOSE-DENSE EPIRUBICIN (E), PACLITAXEL (T), CYCLOPHOSPHAMIDE (C) (IDDETC) IS HIGHLY EFFECTIVE IN ADJUVANT THERAPY OF NODE-POSITIVE BREAST CANCER PATIENTS (PTS). AN ANALYSIS OF THE GBG, AGO-B, AND NOGGO STUDY GROUPS.},
  author={Christoph Thomssen and Gunter von Minckwitz and Christian Jackisch and Hans Joachim L{\"u}ck and Andreas Schneeweiss and Hans Tesch and Dirk Elling and Nadia Harbeck and Bettina Conrad and Tanja N. Fehm and Jens Huober and V M{\"u}ller and Ingo Bauerfeind and Sibylle Loibl and Valentina Nekljudova and Michael Untch and Volker J M{\"o}bus},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2014},
  volume={25 suppl_4},
  pages={iv86-iv87}
}

Topics from this paper.